,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,155,1,1,,401238,98285,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
1,157,1,1,,401238,98285,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
2,161,1,1,,401238,98285,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
3,165,1,1,,401238,98285,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
4,167,1,1,,401238,98285,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
5,175,1,1,,401238,98285,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
6,330,1,1,,401238,98285,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
7,422,1,5,,24338600,98285,Inactive,21464101.0,7532.0,,,HTS for 14-3-3 protein interaction modulators,Screening,,
8,436,2,1,,24338600,98285,Inactive,68565074.0,8314.0,,,HTS for BAP1 Enzyme inhibitors,Screening,,
9,608,1,6,,11536872,98285,Inactive,17149836.0,2280.0,,,NMR Based Screening Assay for FKBP12,Other,,
10,745,1,3,,24338600,98285,Inactive,,,,,Non-Nucleoside Inhibitor of Measles Virus RNA-Dependent RNA Polymerase Complex Activity HTS Single Point,Screening,,
11,811,1,2,,26527985,98285,Inactive,55662034.0,,,,Primary Cell Based High Throughput Screening Assay for Inhibitors of TLR4-MyD88 binding,Screening,,
12,833,1,2,,26527985,98285,Inactive,2578455.0,29234.0,,,Primary Cell Based High Throughput Screening Assay for Agonists of GALR2,Screening,,
13,1033,2,2,,11536872,98285,Inactive,216546.0,,,,NMR Based Screening Assay for the substrate binding domain of the chaperone DnaK,Screening,,
14,1044,1,1,,26527985,98285,Inactive,13027636.0,1901.0,,,Primary cell-based high-throughput screening assay to identify agonists of Sphingosine 1-Phosphate receptor 1 (S1P1),Screening,,
15,1549,1,2,,11536872,98285,Inactive,89033149.0,,,,NMR Based Screening Assay for Novel Chemotypes against influenza A virus,Other,,
16,1552,1,3,,11536872,98285,Inactive,4507793.0,7334.0,,,NMR assay targeting the ubiquitin-proteasome system to modulate protein folding and degradation,Other,,
17,1637,1,2,,11536872,98285,Inactive,,,,,NMR Based Screening Assay for Influenza A RNA Promoter,Other,,
18,1648,1,2,,11536872,98285,Inactive,159164579.0,,,,NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR,Other,,
19,1792,1,1,,26527985,98285,Inactive,83699673.0,27035.0,,,Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of NADPH oxidase 1 (Nox1): Maybridge Library,Screening,,
20,1823,1,1,,26527985,98285,Inactive,,,,,Luminescence-based counterscreen for inhibitors of NADPH oxidase 1 (Nox1): biochemical high throughput screening assay to identify inhibitors of luminol (Maybridge Library),Screening,,
21,2291,1,3,,26527985,98285,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based Maybridge primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
22,41995,7,1,,103391325,98285,Active,,,22.0,IC50,Concentration that inhibits specific [3H]flunitrazepam binding to benzodiazepine receptor in bovine brain,Confirmatory,6300400.0,
23,42171,3,11,,103391325,98285,Unspecified,120757.0,14395.0,,,In vivo inhibition of [3H]flunitrazepam binding to mouse brain 10 minute after 15 uM/kg iv dose (ND = no data),Other,6300400.0,
24,42171,3,11,,103391325,98285,Unspecified,120760.0,14396.0,,,In vivo inhibition of [3H]flunitrazepam binding to mouse brain 10 minute after 15 uM/kg iv dose (ND = no data),Other,6300400.0,
25,42171,3,11,,103391325,98285,Unspecified,120792.0,14403.0,,,In vivo inhibition of [3H]flunitrazepam binding to mouse brain 10 minute after 15 uM/kg iv dose (ND = no data),Other,6300400.0,
26,42171,3,11,,103391325,98285,Unspecified,1730183.0,14400.0,,,In vivo inhibition of [3H]flunitrazepam binding to mouse brain 10 minute after 15 uM/kg iv dose (ND = no data),Other,6300400.0,
27,42171,3,11,,103391325,98285,Unspecified,13959377.0,14397.0,,,In vivo inhibition of [3H]flunitrazepam binding to mouse brain 10 minute after 15 uM/kg iv dose (ND = no data),Other,6300400.0,
28,42171,3,11,,103391325,98285,Unspecified,13959379.0,57249.0,,,In vivo inhibition of [3H]flunitrazepam binding to mouse brain 10 minute after 15 uM/kg iv dose (ND = no data),Other,6300400.0,
29,42171,3,11,,103391325,98285,Unspecified,20141351.0,14406.0,,,In vivo inhibition of [3H]flunitrazepam binding to mouse brain 10 minute after 15 uM/kg iv dose (ND = no data),Other,6300400.0,
30,42171,3,11,,103391325,98285,Unspecified,51317299.0,14394.0,,,In vivo inhibition of [3H]flunitrazepam binding to mouse brain 10 minute after 15 uM/kg iv dose (ND = no data),Other,6300400.0,
31,42171,3,11,,103391325,98285,Unspecified,52000959.0,14402.0,,,In vivo inhibition of [3H]flunitrazepam binding to mouse brain 10 minute after 15 uM/kg iv dose (ND = no data),Other,6300400.0,
32,42171,3,11,,103391325,98285,Unspecified,62901524.0,216643.0,,,In vivo inhibition of [3H]flunitrazepam binding to mouse brain 10 minute after 15 uM/kg iv dose (ND = no data),Other,6300400.0,
33,42171,3,11,,103391325,98285,Unspecified,66774012.0,110886.0,,,In vivo inhibition of [3H]flunitrazepam binding to mouse brain 10 minute after 15 uM/kg iv dose (ND = no data),Other,6300400.0,
34,42171,3,11,,103391325,98285,Unspecified,341941084.0,14399.0,,,In vivo inhibition of [3H]flunitrazepam binding to mouse brain 10 minute after 15 uM/kg iv dose (ND = no data),Other,6300400.0,
35,42171,3,11,,103391325,98285,Unspecified,408360110.0,14405.0,,,In vivo inhibition of [3H]flunitrazepam binding to mouse brain 10 minute after 15 uM/kg iv dose (ND = no data),Other,6300400.0,
36,42171,3,11,,103391325,98285,Unspecified,408360111.0,14407.0,,,In vivo inhibition of [3H]flunitrazepam binding to mouse brain 10 minute after 15 uM/kg iv dose (ND = no data),Other,6300400.0,
37,434982,1,2,,26527985,98285,Inactive,11275980.0,4851.0,,,Cell-based luminescence-based Maybridge primary high throughput screening assay to identify agonists of NOTCH,Screening,,
38,492967,1,2,,92192954,98285,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
39,492967,1,2,,92254622,98285,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
40,602314,1,2,,92192954,98285,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
41,602314,1,2,,92254622,98285,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
42,652031,1,1,,26527985,98285,Inactive,119607129.0,4986.0,,,Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay,Screening,,
43,1091974,1,1,,103391325,98285,Active,,,,,Insecticidal activity against Lipaphis erysimi (mustard aphids) assessed as increase in mortality at 50 to 200 mg/L after 24 to 48 hr,Other,21060288.0,
44,1091980,1,1,,103391325,98285,Active,,,,,Insecticidal activity against fourth-instar larval stage of Culex quinquefasciatus assessed as increase in mortality at 50 to 100 mg/L after 24 hr,Other,21060288.0,
45,1091983,1,2,,103391325,98285,Unspecified,,,,,Cytotoxicity against Spodoptera frugiperda (fall armyworm) Sf9 cells assessed as growth inhibition at 200 mg/L after 24 hr by MTT assay,Other,21060288.0,
46,1091984,1,1,,103391325,98285,Unspecified,,,,,Insecticidal activity against fourth-instar larval stage of Culex quinquefasciatus assessed as increase in mortality after 2 to 24 hr,Other,21060288.0,
47,1091985,1,1,,103391325,98285,Unspecified,,,,,Insecticidal activity against fourth-instar larval stage of Culex quinquefasciatus assessed as mortality at 1 mg/L after 24 hr,Other,21060288.0,
48,1194597,1,2,,103391325,98285,Unspecified,131467.0,5770.0,,,Inhibition of PTP1B (unknown origin) assessed as inhibition rate at 100 uM,Other,25819098.0,
49,1224905,2,1,,92192954,98285,Inactive,120997.0,25643.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
50,1224905,2,1,,92192954,98285,Inactive,74356043.0,55704.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
51,1243199,1,1,,103391325,98285,Inconclusive,,,,IC50,Cytotoxicity against human HL60 cells incubated for 48 hrs by MTT assay,Confirmatory,26235951.0,
52,1243200,1,1,,103391325,98285,Inconclusive,,,,IC50,Cytotoxicity against human Hep3B cells incubated for 48 hrs by MTT assay,Confirmatory,26235951.0,
53,1243201,1,1,,103391325,98285,Unspecified,,,50.0,IC50,Cytotoxicity against human H460 cells incubated for 48 hrs by MTT assay,Confirmatory,26235951.0,
54,1243202,1,1,,103391325,98285,Unspecified,,,50.0,IC50,Cytotoxicity against human A498 cells incubated for 48 hrs by MTT assay,Confirmatory,26235951.0,
55,1243203,1,1,,103391325,98285,Unspecified,,,50.0,IC50,Cytotoxicity against human COLO205 cells incubated for 48 hrs by MTT assay,Confirmatory,26235951.0,
56,1243204,1,1,,103391325,98285,Inconclusive,,,,IC50,Cytotoxicity against human 2774 cells incubated for 48 hrs by MTT assay,Confirmatory,26235951.0,
57,1243205,1,1,,103391325,98285,Inconclusive,,,,IC50,Cytotoxicity against human SKOV3 cells incubated for 48 hrs by MTT assay,Confirmatory,26235951.0,
58,1243206,1,1,,103391325,98285,Inconclusive,,,,IC50,Cytotoxicity against human Detroit 551 cells incubated for 48 hrs by MTT assay,Confirmatory,26235951.0,
59,1259310,1,1,,333274630,98285,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
60,1259370,2,2,,124639087,98285,Active,312803.0,1017.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
61,1259370,2,2,,124639087,98285,Active,510604.0,890.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
62,1259370,2,2,,124639087,98285,Active,14602917.0,994.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
63,1259407,1,1,,363904436,98285,Inactive,,,,,CCRIS mutagenicity studies,Other,,
